Michel Velez
Impact in
-
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 10
- Lung Cancer Research Studies 6
-
- Lung Cancer Treatments and Mutations 7
- Lung Cancer Diagnosis and Treatment 3
- Co-authors
- Edgardo S. Santos (7 shared papers)Luis E. Raez (11 shared papers)Cesar A. Perez (5 shared papers)Mauricio A. Escobar (1 shared paper)Georges Azzi (1 shared paper)Ronan Swords (1 shared paper)Carlos Carracedo (1 shared paper)Leylah Drusbosky (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Expert Review of Anticancer Therapy (2 papers)BioMed Research International (1 paper)Lung Cancer (1 paper)Future Oncology (1 paper)
- Partner nations
- United StatesBrazil
In The Last Decade
Michel Velez
15 papers receiving 108 citations
Peers
Comparison fields: 5 of 30
- Oncology 47
- Pulmonary and Respiratory Medicine 48
- Cancer Research 21
- Molecular Biology 67
- Genetics 7
Countries citing papers authored by Michel Velez
This map shows the geographic impact of Michel Velez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Velez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Velez more than expected).
Fields of papers citing papers by Michel Velez
This network shows the impact of papers produced by Michel Velez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Velez. The network helps show where Michel Velez may publish in the future.
Co-authors
The 21 scholars most cited alongside Michel Velez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 36 | |
| 2 | 2011 | 26 | |
| 3 | 2010 | 12 | |
| 4 | 2014 | 10 | |
| 5 | 2012 | 7 | |
| 6 | 2013 | 6 | |
| 7 | 2021 | 4 | |
| 8 | 2024 | 2 | |
| 9 | Initial Response to Therapy with Fulvestrant and Cyclin-Dependent Kinase 4/6 Inhibitor in a Male with Stage IV Breast Cancer | 2017 | 1 |
| 10 | 2017 | 1 | |
| 11 | 2012 | 1 | |
| 12 | 2017 | 1 | |
| 13 | 2018 | 1 | |
| 14 | Safety and Efficacy of Pemetrexed in Maintenance Therapy of Non-Small Cell Lung Cancer | 2013 | 1 |
| 15 | 2010 | 1 | |
| 16 | 2017 | 0 |
About Michel Velez
Michel Velez is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Surgery, having authored 16 papers that have together received 110 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (6 papers), Cancer Genomics and Diagnostics (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Cancer-related molecular mechanisms research (2 papers), Cancer therapeutics and mechanisms (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Oncology (47 citations), Pulmonary and Respiratory Medicine (48 citations), Cancer Research (21 citations), Molecular Biology (67 citations) and Genetics (7 citations). Michel Velez has collaborated with scholars based in United States and Brazil. Frequent co-authors include Edgardo S. Santos, Luis E. Raez, Cesar A. Perez, Mauricio A. Escobar, Georges Azzi, Ronan Swords, Carlos Carracedo, Leylah Drusbosky, Lazaros J. Lekakis and Jennifer W. Carlisle. Their work appears in journals such as Journal of Clinical Oncology, Expert Review of Anticancer Therapy, BioMed Research International, Lung Cancer and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.